Literature DB >> 24585099

Natural history of vertically acquired HCV infection and associated autoimmune phenomena.

Silvia Garazzino1, Carmelina Calitri, Antonella Versace, Alda Alfarano, Carlo Scolfaro, Chiara Bertaina, Simona Vatrano, Federica Mignone, Francesco Licciardi, Clara Gabiano, Pier-Angelo Tovo.   

Abstract

UNLABELLED: The natural history of vertically acquired HCV infection is ill defined. The aim of this study was to outline the natural course of vertical HCV infection in a cohort of untreated children, including rate of spontaneous viral clearance, frequency and features of HCV-related autoimmune disorders. Children with vertical HCV infection were prospectively followed from the first month of life with regular clinical and laboratory assessments. Statistical analysis was performed using Prism 5.0. Forty-five children (median age 12 years, interquartile range 6.9-15.5) were studied. Genotype 1 was predominant (53.3 %). Spontaneous viral clearance was achieved by 12 patients (26.7 %) and associated with genotype 3. Alanine-amino-transferase levels were increased in most children in the first 2 years of life with higher values in those who later cleared the infection. All children were asymptomatic for liver disease. Transient elastography (32 patients) showed mild or moderate fibrosis in nine and two cases, respectively. Non-organ-specific autoantibodies were detected in 24 children (53.3 %) independently of viremia; of these, one developed type-1 diabetes. Cryoglobulinemia was associated with genotype 1 infection and found in 15 subjects (33.3 %): two had low C4 levels and persistent proteinuria.
CONCLUSIONS: Vertically acquired HCV infection may result in spontaneous clearance in up to 27 % of children. Resolution of infection is higher with genotype 3, usually occurs in preschool age and persists over time. Chronic infection is generally asymptomatic, although hepatomegaly and mild fibrosis may develop. Autoantibodies and cryoglobulins are frequent, whereas the associated clinical manifestations are rare.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24585099     DOI: 10.1007/s00431-014-2286-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

1.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women.

Authors:  D Conte; M Fraquelli; D Prati; A Colucci; E Minola
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Spontaneous clearance of hepatitis C virus in vertically infected children.

Authors:  Susan Farmand; Stefan Wirth; Helga Löffler; Tanja Woltering; Sybille Kenzel; Elke Lainka; Philipp Henneke
Journal:  Eur J Pediatr       Date:  2011-07-07       Impact factor: 3.183

3.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

Authors:  M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

4.  Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha.

Authors:  Stephan Gehring; Ulrike Kullmer; Sabine Koeppelmann; Patrick Gerner; Philip Wintermeyer; Stefan Wirth
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

Review 5.  Hepatitis C-Z: recent advances.

Authors:  D Kelly; S Skidmore
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

6.  Application and limitations of transient liver elastography in children.

Authors:  Imeke Goldschmidt; Carolin Streckenbach; Carmen Dingemann; Eva Doreen Pfister; André di Nanni; Antonia Zapf; Ulrich Baumann
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

7.  Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.

Authors:  T Stroffolini; G Colloredo; G B Gaeta; A Sonzogni; S Angeletti; M Marignani; G Pasquale; G Venezia; A Craxì; P Almasio
Journal:  J Viral Hepat       Date:  2004-05       Impact factor: 3.728

8.  Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease.

Authors:  Flavia Bortolotti; Gabriella Verucchi; Calogero Cammà; Giuseppe Cabibbo; Lucia Zancan; Giuseppe Indolfi; Raffaella Giacchino; Matilde Marcellini; Maria Grazia Marazzi; Cristiana Barbera; Giuseppe Maggiore; Pietro Vajro; Samuela Bartolacci; Fiorella Balli; Anna Maccabruni; Maria Guido
Journal:  Gastroenterology       Date:  2008-03-02       Impact factor: 22.682

9.  Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.

Authors:  V S Wong; W Egner; T Elsey; D Brown; G J Alexander
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

10.  Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.

Authors:  M Lenzi; S Bellentani; G Saccoccio; P Muratori; F Masutti; L Muratori; F Cassani; F B Bianchi; C Tiribelli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

View more
  12 in total

Review 1.  What's new in hepatitis C virus infections in children?

Authors:  Malgorzata Pawlowska; Krzysztof Domagalski; Anna Pniewska; Beata Smok; Waldemar Halota; Andrzej Tretyn
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Hepatitis C virus infection in mothers and children.

Authors:  Emma Greenaway; Mia J Biondi; Jordan J Feld; Simon C Ling
Journal:  Can Liver J       Date:  2019-12-10

Review 3.  Treatment of hepatitis C in children and adolescents: how far have we reached?

Authors:  Vybhav Venkatesh; Keerthivasan Seetharaman; Neha Anushree
Journal:  World J Pediatr       Date:  2022-09-21       Impact factor: 9.186

Review 4.  Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.

Authors:  Pier-Angelo Tovo; Carmelina Calitri; Carlo Scolfaro; Clara Gabiano; Silvia Garazzino
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

5.  Nucleic Acid Testing for Diagnosis of Perinatally Acquired Hepatitis C Virus Infection in Early Infancy.

Authors:  Charitha Gowda; Stephanie Smith; Linda Crim; Katherine Moyer; Pablo J Sánchez; Jonathan R Honegger
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

Review 6.  Hepatitis C virus infection in children and adolescents.

Authors:  James E Squires; William F Balistreri
Journal:  Hepatol Commun       Date:  2017-03-23

Review 7.  The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.

Authors:  Christine Hong Ting Yang; Eric R Yoo; Aijaz Ahmed
Journal:  J Clin Transl Hepatol       Date:  2017-02-07

Review 8.  Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis.

Authors:  Marianna G Mavilia; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-06-07

Review 9.  New prospects for the treatment and prevention of hepatitis C in children.

Authors:  Samantha Ohmer; Jonathan Honegger
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

Review 10.  Breakthroughs and challenges in the management of pediatric viral hepatitis.

Authors:  Emanuele Nicastro; Lorenzo Norsa; Angelo Di Giorgio; Giuseppe Indolfi; Lorenzo D'Antiga
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.